Terumo Neuro’s Sofia 88 Support Catheter Launched in United States

May 13, 2025—Terumo Neuro, a wholly owned subsidiary of Terumo Corporation, announced the commercial availability of the Sofia 88 neurovascular support catheter.

According to the company, the new Sofia device is a large-bore catheter with an 0.088-inch inner diameter engineered for reliability, procedural flexibility, and physician control. The launch builds on the clinical performance of the Sofia catheter line, noted Terumo Neuro.

Terumo Neuro stated that the Sofia 88 features engineering enhancements designed to provide reliable trackability through challenging anatomy via optimized transition zones and a soft, atraumatic distal tip; proximal stability for procedural ease with both short and long sheaths; and flexibility and reinforcement through the entire working length to minimize vessel trauma and support smooth navigation.

“Terumo Neuro’s Sofia 88 neurovascular support catheter is truly one of the best products in this category, especially when using a short 8-F sheath,” commented Ameer Hassan, DO, in the company’s press release. “It has great trackability, and it is improving my access whether I decide to use it to support an aspiration only or a combination approach—it really does improve my first pass effect.”

Dr. Hassan is Head of Neuroscience Department at Valley Baptist, Professor of Neurology, University of Texas Rio Grande Valley in Harlingen, Texas.

Terumo Neuro advised that the Sofia 88 device is compatible with the Sofia Flow Plus 6-F aspiration catheter and supports integration into existing aspiration strategies. Clinical evidence from the SOFAST registry, which evaluated the Sofia Flow Plus 6 F as a first-line approach, demonstrated strong results across speed, efficacy, safety, and overall clinical outcomes. In July 2024, the company announced that results from SOFAST were published by Dheeraj Gandhi, MD, et al online in Journal of NeuroInterventional Surgery.

Additionally, the new Sofia 88 catheter also complements the company’s broader stroke solution portfolio to offer a fully integrated approach across aspiration, access, retrieval, and navigation, stated Terumo Neuro.